|
2025
|
Invention
|
Systems and methods for virtual reality, augmented reality, and/or mixed reality based visual fun... |
|
|
Invention
|
C3 targeted inhibitory rna. The present disclosure relates to C3 targeted inhibitory RNA sequence... |
|
|
Invention
|
Dosing regimens and related compositions and methods. In some aspects, the present invention prov... |
|
|
Invention
|
Dosing regimens and related compositions and methods.
In some aspects, the present invention pro... |
|
2024
|
Invention
|
Compositions and methods for altering complement activation. Compositions and methods for reducin... |
|
|
G/S
|
Providing information about medication insurance coverage, enrollment in patient benefits program... |
|
|
Invention
|
Methods of using geographic atrophy lesion characteristics. The present disclosure encompasses me... |
|
|
Invention
|
Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods. ... |
|
|
Invention
|
Complement inhibition. Among other things, the present disclosure provides technologies for modul... |
|
|
G/S
|
Organization, production and presentation of exhibitions and
displays in the nature of education... |
|
|
G/S
|
Organization, production and presentation of exhibitions and displays in the nature of education ... |
|
2023
|
Invention
|
Dosing regimens.
In some aspects, the present invention provides cell-reactive compstatin analog... |
|
|
G/S
|
Organization, production and presentation of exhibitions and displays for educational purposes pe... |
|
|
Invention
|
Treatment of geographic atrophy. Methods and compositions for treatment of geographic atrophy are... |
|
|
Invention
|
Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof.
In some aspects, th... |
|
2022
|
Invention
|
Rnas for complement inhibition.
RNAs, such as miRNA and siRNA, and their use in treating complem... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of
complement-mediated diseases and disorders. |
|
|
G/S
|
Pharmaceutical preparations, solely for human use, for the treatment of complement-mediated disea... |
|
|
Invention
|
Complement inhibitor dosing regimens. Complement is an arm of the innate immune system that plays... |
|
|
Invention
|
Systems and methods for virtual reality, augmented reality, and mixed reality based visual functi... |
|
|
Invention
|
Compositions and methods for genome editing the neonatal fc receptor.
Provided herein are compos... |
|
|
Invention
|
Compositions and methods for genome editing the neonatal fc receptor. Provided herein are composi... |
|
|
Invention
|
Rnas for complement inhibition. RNAs, such as miRNA and siRNA, and their use in treating compleme... |
|
|
Invention
|
Complement inhibition.
Among other things, the present disclosure provides technologies for modu... |
|
|
Invention
|
Cell-penetrating compstatin analogs and uses thereof.
In some aspects, the present invention cel... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of complement-mediated diseases and disorders |
|
|
G/S
|
Medical devices, namely, infusion pumps |
|
|
Invention
|
Genomic editing of complement.
Complement activation occurs via three main pathways: the antibod... |
|
|
Invention
|
Genomic editing of complement. Complement activation occurs via three main pathways: the antibody... |
|
|
Invention
|
Treatment of complement-mediated disorders. Inappropriate or excessive complement activation is a... |
|
|
Invention
|
Combination therapy for c3 inhibition.
In some aspects, the present invention provides certain c... |
|
|
Invention
|
Polypeptides for complement inhibition.
Proteins comprising a C3 and/or C3b binding polypeptide ... |
|
|
Invention
|
Polypeptides for complement inhibition. Proteins comprising a C3 and/or C3b binding polypeptide a... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of complement-mediated diseases and disorders. |
|
2021
|
Invention
|
Genomic editing of complement.
Methods, systems, and compositions for genomic editing of a gene ... |
|
|
Invention
|
Genomic editing of complement. Methods, systems, and compositions for genomic editing of a gene e... |
|
|
Invention
|
Methods of treating eye disorders.
Methods of treating eye disorders, e.g., age related macular ... |
|
|
Invention
|
Methods and compositions for cancer treatment and treatment selection.
In some aspects, the disc... |
|
|
Invention
|
Methods of treating eye disorders. Methods of treating eye disorders, e.g., age related macular d... |
|
|
Invention
|
Compositions and methods relating to c5l2.
In some aspects, provided herein is a method of enhan... |
|
|
Invention
|
Methods of treating chronic disorders with complement inhibitors. In some aspects, the invention ... |
|
|
Invention
|
Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof. In some aspects, the... |
|
|
G/S
|
Infusion pumps for measuring and delivering medication and fluids; medical needles; patient suppo... |
|
|
Invention
|
Treatment of paroxysmal nocturnal hemoglobinuria.
Methods and compositions for treatment of paro... |
|
|
Invention
|
Treatment of paroxysmal nocturnal hemoglobinuria. Methods and compositions for treatment of parox... |
|
2020
|
Invention
|
Cell-penetrating compstatin analogs and uses thereof. In some aspects, the present invention cell... |
|
|
G/S
|
Providing information about medication insurance coverage, benefits verification, reimbursement, ... |
|
|
Invention
|
Complement inhibitor dosing regimens.
Methods and compositions for inhibiting complement are des... |
|
|
Invention
|
Viral vector therapy.
Methods and compositions for combined therapy with viral vectors and compl... |
|
|
Invention
|
Compstatin analogs for treatment of neuropathic pain.
In some aspects, the present invention pro... |
|
|
G/S
|
Pharmaceutical preparations, solely for human use, for the
treatment of complement-mediated dise... |
